183 related articles for article (PubMed ID: 29222961)
61. Relation between localization and function of rat liver Kupffer cells.
Sleyster EC; Knook DL
Lab Invest; 1982 Nov; 47(5):484-90. PubMed ID: 6182391
[TBL] [Abstract][Full Text] [Related]
62. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
[TBL] [Abstract][Full Text] [Related]
63. Recent advances in fructose intake and risk of hyperuricemia.
Zhang C; Li L; Zhang Y; Zeng C
Biomed Pharmacother; 2020 Nov; 131():110795. PubMed ID: 33152951
[TBL] [Abstract][Full Text] [Related]
64. Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet.
Wang XH; Li CY; Muhammad I; Zhang XY
Environ Toxicol Pharmacol; 2016 Jun; 44():140-50. PubMed ID: 27179602
[TBL] [Abstract][Full Text] [Related]
65. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
66. Differential gene expression in periportal and perivenous mouse hepatocytes.
Braeuning A; Ittrich C; Köhle C; Hailfinger S; Bonin M; Buchmann A; Schwarz M
FEBS J; 2006 Nov; 273(22):5051-61. PubMed ID: 17054714
[TBL] [Abstract][Full Text] [Related]
67. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
68. Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.
Lin H; Li Q; Liu X; Ma H; Xia M; Wang D; Li X; Wu J; Zhao N; Pan B; Gao X
PLoS One; 2015; 10(10):e0140379. PubMed ID: 26473493
[TBL] [Abstract][Full Text] [Related]
69. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
70. Fatty liver promotes fibrosis in monkeys consuming high fructose.
Cydylo MA; Davis AT; Kavanagh K
Obesity (Silver Spring); 2017 Feb; 25(2):290-293. PubMed ID: 28124507
[TBL] [Abstract][Full Text] [Related]
71. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
[TBL] [Abstract][Full Text] [Related]
72. Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.
Huang Q; Yu J; Zhang X; Liu S; Ge Y
Biomed Rep; 2016 Aug; 5(2):188-192. PubMed ID: 27446539
[TBL] [Abstract][Full Text] [Related]
73. Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging.
Seubnooch P; Montani M; Tsouka S; Claude E; Rafiqi U; Perren A; Dufour JF; Masoodi M
JHEP Rep; 2023 Jun; 5(6):100725. PubMed ID: 37284141
[TBL] [Abstract][Full Text] [Related]
74. Functional heterogeneity of periportal and perivenous hepatocytes.
Jungermann K
Enzyme; 1986; 35(3):161-80. PubMed ID: 3530741
[TBL] [Abstract][Full Text] [Related]
75. Uric acid in metabolic syndrome: From an innocent bystander to a central player.
Kanbay M; Jensen T; Solak Y; Le M; Roncal-Jimenez C; Rivard C; Lanaspa MA; Nakagawa T; Johnson RJ
Eur J Intern Med; 2016 Apr; 29():3-8. PubMed ID: 26703429
[TBL] [Abstract][Full Text] [Related]
76. Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis.
Kurosaki S; Nakagawa H; Hayata Y; Kawamura S; Matsushita Y; Yamada T; Uchino K; Hayakawa Y; Suzuki N; Hata M; Tsuboi M; Kinoshita H; Tanaka Y; Nakatsuka T; Hirata Y; Tateishi K; Koike K
JHEP Rep; 2021 Aug; 3(4):100315. PubMed ID: 34345813
[TBL] [Abstract][Full Text] [Related]
77. Hepatic Macrophage Types Cluster with Disease Etiology in Chronic Liver Disease and Differ Compared to Normal Liver: Implications for Their Biologic and Diagnostic Role.
Zhang X; Thompkins-Johns A; Ziober A; Zhang PJ; Furth EE
Int J Surg Pathol; 2023 May; 31(3):268-279. PubMed ID: 35521912
[No Abstract] [Full Text] [Related]
78. Distribution of albumin, alpha 1-inhibitor 3 and their respective mRNAs in periportal and perivenous rat hepatocytes isolated by the digitonin-collagenase technique.
Racine L; Scoazec JY; Moreau A; Chassagne P; Bernuau D; Feldmann G
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):263-8. PubMed ID: 7826339
[TBL] [Abstract][Full Text] [Related]
79. Lack of association between dietary fructose and hyperuricemia risk in adults.
Sun SZ; Flickinger BD; Williamson-Hughes PS; Empie MW
Nutr Metab (Lond); 2010 Mar; 7():16. PubMed ID: 20193069
[TBL] [Abstract][Full Text] [Related]
80. Periportal steatosis in mice affects distinct parameters of pericentral drug metabolism.
Albadry M; Höpfl S; Ehteshamzad N; König M; Böttcher M; Neumann J; Lupp A; Dirsch O; Radde N; Christ B; Christ M; Schwen LO; Laue H; Klopfleisch R; Dahmen U
Sci Rep; 2022 Dec; 12(1):21825. PubMed ID: 36528753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
